BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26639052)

  • 1. CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells.
    Zhu R; Zhang CG; Liu Y; Yuan ZQ; Chen WL; Yang SD; Li JZ; Zhu WJ; Zhou XF; You BG; Zhang XN
    Sci Rep; 2015 Dec; 5():17904. PubMed ID: 26639052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 4. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
    Tian H; Huang Y; He J; Zhang M; Ni P
    ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Hederin induces paraptosis by targeting GPCRs to activate Ca
    Rao X; Li Z; Zhang Q; Lai Y; Liu J; Li L; Cheng H; Shen W; Sun D
    Cancer Med; 2024 Apr; 13(8):e7202. PubMed ID: 38659391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
    Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
    Zhao L; Yang G; Shi Y; Su C; Chang J
    J Nanobiotechnology; 2015 Sep; 13():57. PubMed ID: 26395758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and tumor cytotoxicity of novel amide derivatives of β-hederin.
    Liu Y; Lu WX; Yan MC; Yu Y; Ikejima T; Cheng MS
    Molecules; 2010 Nov; 15(11):7871-83. PubMed ID: 21060295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.
    Qu C; Li J; Zhou Y; Yang S; Chen W; Li F; You B; Liu Y; Zhang X
    AAPS J; 2018 Feb; 20(2):34. PubMed ID: 29476273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
    Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
    Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
    Rejinold NS; Muthunarayanan M; Divyarani VV; Sreerekha PR; Chennazhi KP; Nair SV; Tamura H; Jayakumar R
    J Colloid Interface Sci; 2011 Aug; 360(1):39-51. PubMed ID: 21549390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
    Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG
    World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
    Bu L; Gan LC; Guo XQ; Chen FZ; Song Q; Qi-Zhao ; Gou XJ; Hou SX; Yao Q
    Int J Pharm; 2013 Aug; 452(1-2):355-62. PubMed ID: 23685116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles.
    Liang J; Li F; Fang Y; Yang W; An X; Zhao L; Xin Z; Cao L; Hu Q
    Colloids Surf B Biointerfaces; 2011 Feb; 82(2):297-301. PubMed ID: 20888740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
    Jeevitha D; Amarnath K
    Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
    Almutairi FM; Abd-Rabou AA; Mohamed MS
    Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.